Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Cellular senescence
Research brief

Chronic infection proposed as a modifiable driver of cardiac aging

The abstract proposes that chronic infections may prematurely induce aging-like changes in the heart through persistent inflammation, and frames anti-infective strategies as part of cardiovascular longevity care. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The abstract states that cardiovascular diseases are the leading cause of global mortality and advanced age the most significant risk factor. [1]

  2. It proposes that chronic infections trigger cardiomyocyte senescence via disrupted mTOR signaling and impaired autophagy. [1]

  3. It proposes that immune subversion accelerates left ventricular hypertrophy, myocardial remodeling and interstitial fibrosis. [1]

The source at a glance

Study type / format
Perspective abstract
Population / context
People with chronic infections and cardiac aging, discussed in a perspective abstract
Summary based on
Study abstract
Original publication
July 1, 2026

Proposed link between chronic infection and heart aging

The abstract notes that cardiovascular diseases are the leading cause of global mortality and that advanced age is the most significant risk factor. It proposes that chronic infections with viruses, bacteria or parasites that evade clearance could act as catalysts for cardiac decline by prematurely inducing aging phenotypes. This is presented as a perspective, not as an established causal finding.

Supporting source [1]

Proposed mechanisms: inflammation, senescence and remodeling

According to the abstract, persistent infections create a state of permanent inflammaging, a chronic low-grade inflammatory environment with ongoing cytokine signaling and leukocyte infiltration. Mechanistically, it proposes that chronic infection disrupts mTOR signaling and impairs autophagy, triggering cardiomyocyte senescence, and drives mitochondrial dysfunction and excess reactive oxygen species, leading to oxidative DNA damage and metabolic exhaustion. Structurally, it proposes that immune subversion via macrophage polarization and autoimmunity accelerates left ventricular hypertrophy, myocardial remodeling and interstitial fibrosis.

Supporting source [1]

Abstract-only perspective without reported data

The text is a perspective arguing that chronic infection be characterized as a modifiable driver of biological aging, so that anti-infective strategies could be prioritized in cardiovascular longevity and geriatric care. The abstract reports no study design, sample, follow-up or measured outcomes, and the full text was not reviewed. The proposed mechanisms and the framing of infection as modifiable are suggestions, not demonstrated causal effects in people.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. No study design, sample, follow-up or measured outcomes are reported, and the proposed mechanisms are not demonstrated causal effects in humans.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Chronic Infection and Cardiac Aging: a New Perspective on Pathogen-Associated Cardiomyopathy.

Walsh N, DeCesare S, Patel K, Iqbal TW, Nasuhidehnavi A. · europepmc.org · July 1, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    primary driver of global mortality
  2. Finding 2 ↑

    triggering cardiomyocyte senescence through the dysregulation of
  3. Finding 3 ↑

    accelerates left ventricular hypertrophy, myocardial remodeling, and

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…